STAAR Surgical's COO and CFO Step Into Interim Co-CEO Roles Following Leadership Transition

STAAR Surgical Company (STAA), known for its implantable eye lens technologies, has named Warren Foust, its Chief Operating Officer (COO), and Deborah Andrews, its Chief Financial Officer (CFO), as interim Co-Chief Executive Officers, with the appointment taking effect on February 1. The move follows the departure of the company's previous chief executive earlier in January.

To identify a permanent successor, the company has established a search committee tasked with evaluating both internal and external candidates for the permanent CEO position. On trading Friday, STAA shares closed at $18.95, representing a marginal gain of 0.05% on the Nasdaq platform. The company's leadership structure now places its COO in a prominent interim role as the organization transitions toward a permanent executive appointment.